HWKN · Hawkins Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q3 '26 | Q2 '26 | Q1 '25 | Q3 '25 | Q2 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | $244.08M | $280.43M | $293.27M | $226.21M | $247.03M | $251.12M | $208.50M | $236.53M | $241.19M |
| Cost of Revenue | - | $193.27M | $212.79M | $220.91M | $177.78M | $186.81M | $199.13M | $166.25M | $182.64M | $194.82M |
| Gross Profit | - | $50.81M | $67.64M | $72.36M | $48.42M | $60.22M | $51.99M | $42.25M | $53.89M | $46.37M |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | $28.26M | $33.70M | $31.03M | $27.36M | $26.48M | $19.50M | $23.77M | $20.89M | $19.84M |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | - | $10.11M | $9.93M | $12.29M | - | - | $7.11M | - | - | - |
| Operating Income | - | $22.56M | $33.94M | $41.33M | $21.06M | $33.74M | $32.49M | $18.47M | $32.99M | $26.54M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | - | $5.27M | $8.23M | $9.83M | $5.26M | $8.87M | $8.25M | $3.27M | $8.77M | $6.71M |
| Net Income | - | $14.31M | $22.60M | $29.18M | $15.02M | $24.12M | $23.43M | $14.88M | $23.22M | $18.00M |
| EPS - Basic | - | $0.69 | $1.09 | $1.41 | $0.72 | $1.16 | $1.12 | $0.72 | $1.11 | $0.86 |
| EPS - Diluted | - | $0.69 | $1.08 | $1.40 | $0.72 | $1.16 | $1.12 | $0.71 | $1.10 | $0.86 |
Balance Sheet
| Line item | Q1 '26 | Q3 '26 | Q2 '26 | Q1 '25 | Q3 '25 | Q2 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.91M | $8.21M | $10.41M | $5.10M | $8.30M | $7.53M | $7.15M | $5.74M | $10.97M | $7.57M |
| Accounts Receivable | $139.80M | $123.74M | $131.09M | $140.11M | $111.52M | $115.22M | $114.48M | $113.02M | $124.81M | $129.25M |
| Inventory | $78.20M | $85.93M | $92.91M | $95.72M | $81.63M | $81.56M | $74.60M | $68.81M | $68.50M | $88.78M |
| Accounts Payable | $59.84M | $46.38M | $55.27M | $62.79M | $39.89M | $50.96M | $56.39M | $42.86M | $61.19M | $53.70M |
| Current Assets | $231.47M | $228.20M | $239.56M | $256.42M | $210.35M | $209.88M | $202.83M | $195.00M | $207.25M | $232.04M |
| Total Assets | $986.29M | $976.53M | $984.16M | $988.27M | $707.24M | $689.70M | $657.93M | $644.05M | $575.30M | $590.53M |
| Current Liabilities | $104.84M | $97.16M | $98.56M | $110.93M | $84.25M | $92.34M | $103.31M | $79.68M | $94.46M | $90.87M |
| Long-term Debt | $244.00M | $253.38M | $268.33M | $288.28M | $103.88M | $93.86M | $88.82M | $109.80M | $49.77M | $101.73M |
| Total Liabilities | $452.28M | $457.62M | $477.20M | $503.70M | $250.26M | $246.32M | $251.91M | $250.29M | $192.64M | $240.52M |
| Stockholders' Equity | $534.01M | $518.91M | $506.97M | $484.57M | $456.98M | $443.37M | $406.03M | $393.75M | $382.66M | $350.02M |
| Retained Earnings | $500.14M | $488.65M | $478.31M | $459.68M | $421.68M | $410.43M | $364.55M | $354.07M | $342.54M | $302.42M |
Cash Flow
| Line item | Q1 '26 | Q3 '26 | Q2 '26 | Q1 '25 | Q3 '25 | Q2 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | $31.49M | - | - | $34.87M | - | - | - |
| Investing Cash Flow | - | - | - | ($164.54M) | - | - | ($7.83M) | - | - | - |
| Financing Cash Flow | - | - | - | $142.45M | - | - | ($27.55M) | - | - | - |
| CapEx | - | - | - | $13.54M | - | - | $7.87M | - | - | - |
| Free Cash Flow | - | - | - | $17.95M | - | - | $26.99M | - | - | - |
Ratios
| Metric | Q1 '26 | Q3 '26 | Q2 '26 | Q1 '25 | Q3 '25 | Q2 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | 20.8% | 24.1% | 24.7% | 21.4% | 24.4% | 20.7% | 20.3% | 22.8% | 19.2% |
| Operating margin | - | 9.2% | 12.1% | 14.1% | 9.3% | 13.7% | 12.9% | 8.9% | 13.9% | 11.0% |
| EBITDA margin | - | 13.4% | 15.6% | 18.3% | - | - | 15.8% | - | - | - |
| Net margin | - | 5.9% | 8.1% | 9.9% | 6.6% | 9.8% | 9.3% | 7.1% | 9.8% | 7.5% |
| Free cash flow margin | - | - | - | 6.1% | - | - | 10.7% | - | - | - |
| FCF / Net income | - | - | - | 0.62 | - | - | 1.15 | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | 11.6% | 12.0% | 10.6% | 12.1% | 10.7% | 7.8% | 11.4% | 8.8% | 8.2% |
| Effective tax rate | - | 26.9% | 26.7% | 25.2% | 25.9% | 26.9% | 26.0% | 18.0% | 27.4% | 27.1% |
| Return on assets | - | 1.5% | 2.3% | 3.0% | 2.1% | 3.5% | 3.6% | 2.3% | 4.0% | 3.0% |
| Return on equity | - | 2.8% | 4.5% | 6.0% | 3.3% | 5.4% | 5.8% | 3.8% | 6.1% | 5.1% |
| Return on invested capital | - | 2.1% | 3.2% | 4.0% | 2.8% | 4.6% | 4.9% | 3.0% | 5.5% | 4.3% |
| Liquidity | ||||||||||
| Current ratio | 2.21 | 2.35 | 2.43 | 2.31 | 2.50 | 2.27 | 1.96 | 2.45 | 2.19 | 2.55 |
| Quick ratio | 1.46 | 1.46 | 1.49 | 1.45 | 1.53 | 1.39 | 1.24 | 1.58 | 1.47 | 1.58 |
| Cash ratio | 0.04 | 0.08 | 0.11 | 0.05 | 0.10 | 0.08 | 0.07 | 0.07 | 0.12 | 0.08 |
| Leverage | ||||||||||
| Debt / Equity | 0.46 | 0.49 | 0.53 | 0.59 | 0.23 | 0.21 | 0.22 | 0.28 | 0.13 | 0.29 |
| Debt / Assets | 0.25 | 0.26 | 0.27 | 0.29 | 0.15 | 0.14 | 0.13 | 0.17 | 0.09 | 0.17 |
| Debt / EBITDA | - | 7.76 | 6.12 | 5.38 | - | - | 2.24 | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.85 | 1.88 | 1.94 | 2.04 | 1.55 | 1.56 | 1.62 | 1.64 | 1.50 | 1.69 |
| Liabilities / Assets | 0.46 | 0.47 | 0.48 | 0.51 | 0.35 | 0.36 | 0.38 | 0.39 | 0.33 | 0.41 |
| Efficiency | ||||||||||
| Asset turnover | - | 0.25 | 0.28 | 0.30 | 0.32 | 0.36 | 0.38 | 0.32 | 0.41 | 0.41 |
| Inventory turnover | - | 2.25 | 2.29 | 2.31 | 2.18 | 2.29 | 2.67 | 2.42 | 2.67 | 2.19 |
| Days sales outstanding | - | 185d | 171d | 174d | 180d | 170d | 166d | 198d | 193d | 196d |
| Days inventory outstanding | - | 162d | 159d | 158d | 168d | 159d | 137d | 151d | 137d | 166d |
| Days payable outstanding | - | 88d | 95d | 104d | 82d | 100d | 103d | 94d | 122d | 101d |
| Cash conversion cycle | - | 260d | 235d | 229d | 266d | 230d | 200d | 255d | 207d | 261d |
| Valuation | ||||||||||
| P / E | - | 212.8x | 163.9x | 102.8x | 174.1x | 108.1x | 68.6x | 99.2x | 53.5x | 50.9x |
| P / B | - | 5.9x | 7.3x | 6.2x | 5.7x | 5.9x | 4.0x | 3.7x | 3.2x | 2.6x |
| P / S | - | 12.5x | 13.2x | 10.2x | 11.6x | 10.6x | 6.4x | 7.1x | 5.2x | 3.8x |
| EV / EBITDA | - | 101.2x | 90.0x | 61.1x | - | - | 42.8x | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | 7.9% | 13.5% | 16.8% | 8.5% | 4.4% | 1.9% | -4.9% | -1.9% | 31.6% |
| Revenue CAGR (3y) | - | 3.6% | 5.2% | 17.4% | 6.5% | 10.5% | 20.6% | 13.4% | 17.0% | 19.9% |
| Revenue CAGR (5y) | - | 11.3% | 13.7% | 14.8% | 13.4% | 12.0% | - | 10.2% | 10.2% | - |
| Gross profit growth (YoY) | - | 4.9% | 12.3% | 39.2% | 14.6% | 11.8% | 11.2% | 16.5% | 16.2% | 24.4% |
| Operating income growth (YoY) | - | 7.1% | 0.6% | 27.2% | 14.0% | 2.3% | 16.6% | 21.0% | 24.3% | 35.3% |
| Net income growth (YoY) | - | -4.7% | -6.3% | 24.5% | 0.9% | 3.9% | 19.0% | 38.7% | 29.0% | 27.4% |
| EPS growth (YoY) | - | -4.2% | -6.9% | 25.0% | 1.4% | 5.5% | 19.1% | 39.2% | 27.9% | 28.4% |
| EPS CAGR (3y) | - | 10.6% | 7.9% | 21.0% | 14.5% | 20.1% | 0.3% | -1.8% | -1.5% | -0.4% |
| EPS CAGR (5y) | - | -1.7% | -1.2% | 8.8% | 10.9% | 5.9% | - | 12.7% | 9.8% | - |
| FCF growth (YoY) | - | - | - | -33.5% | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | 80.0% | - | - | - | - | - | - |
| Book value growth (YoY) | 10.2% | 13.6% | 14.3% | 19.3% | 16.1% | 15.9% | 29.6% | 15.4% | 9.3% | 15.7% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2026-03-29.
Business segments
$1.08B totalWater Treatment$543.30M · 50.1%
Food And Health Sciences$320.70M · 29.6%
Industrial Solutions$219.69M · 20.3%
Product / service
$861.00M totalManufacturedblendedorrepackagedproducts$488.62M · 56.8%
Nutrition$137.99M · 16.0%
Food$99.28M · 11.5%
Agricultural$52.56M · 6.1%
Bulk$49.58M · 5.8%
Pharmaceutical$27.87M · 3.2%
Other$5.11M · 0.6%
Peer comparison
Same SIC group: Wholesale-Chemicals & Allied Products
Comparing HAWKINS INC against the 2 most active filers in the same SIC group.
Dividends
$0.76/share trailing 12 months · +5.6% YoY
| Ex-date | Per share |
|---|---|
| May 29, 2026 | $0.1900 |
| Feb 13, 2026 | $0.1900 |
| Nov 14, 2025 | $0.1900 |
| Aug 15, 2025 | $0.1900 |
| May 30, 2025 | $0.1800 |
| Feb 14, 2025 | $0.1800 |
| Nov 15, 2024 | $0.1800 |
| Aug 16, 2024 | $0.1800 |
| May 31, 2024 | $0.1600 |
| Feb 15, 2024 | $0.1600 |
| Nov 16, 2023 | $0.1600 |
| Aug 17, 2023 | $0.1600 |
| Jun 1, 2023 | $0.1500 |
| Feb 16, 2023 | $0.1500 |
| Nov 17, 2022 | $0.1400 |
| Aug 18, 2022 | $0.1400 |
| Jun 2, 2022 | $0.1400 |
| Feb 17, 2022 | $0.1400 |
| Nov 4, 2021 | $0.1300 |
| Aug 12, 2021 | $0.1300 |
| Jun 3, 2021 | $0.1230 |
| Feb 11, 2021 | $0.1225 |
| Nov 5, 2020 | $0.1165 |
| Aug 13, 2020 | $0.1165 |